Company profile for Veru

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Veru Inc. is an oncology and urology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer. The Company’s prostate cancer pipeline includes VERU-111, Zuclomiphene citrate and VERU-100. VERU-111 is an oral, next-generation, first-in-class small molecule that targets and disrupts alpha and beta tubulin subunits of microtubules in cells to treat metastatic prostate cancer pat...
Veru Inc. is an oncology and urology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer. The Company’s prostate cancer pipeline includes VERU-111, Zuclomiphene citrate and VERU-100. VERU-111 is an oral, next-generation, first-in-class small molecule that targets and disrupts alpha and beta tubulin subunits of microtubules in cells to treat metastatic prostate cancer patients whose disease is resistant to both castration and novel androgen blocking agents (abiraterone or enzalutamide).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
48 NW 25th St. Suite 102 Miami, FL 33127
Telephone
Telephone
1-305-509-6897
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/31/3178310/11676/en/Veru-to-Present-Two-Abstracts-at-ObesityWeek-2025.html

GLOBENEWSWIRE
31 Oct 2025

https://www.globenewswire.com/news-release/2025/10/30/3177311/11676/en/Veru-Announces-Pricing-of-25-Million-Public-Offering.html

GLOBENEWSWIRE
30 Oct 2025
Veru Announces Proposed Public Offering
Veru Announces Proposed Public Offering

29 Oct 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/10/29/3176830/11676/en/Veru-Announces-Proposed-Public-Offering.html

GLOBENEWSWIRE
29 Oct 2025

https://www.globenewswire.com/news-release/2025/09/23/3154675/11676/en/Veru-Announces-Successful-FDA-Meeting-Providing-Regulatory-Clarity-for-Enobosarm-for-Muscle-Preservation-in-Combination-with-GLP-1-RA-for-Greater-Weight-Loss-in-the-Treatment-of-Ob.html

GLOBENEWSWIRE
23 Sep 2025

https://www.globenewswire.com/news-release/2025/08/12/3131513/11676/en/Veru-Reports-Fiscal-2025-Third-Quarter-Financial-Results-and-Clinical-Program-Progress.html

GLOBENEWSWIRE
12 Aug 2025

https://www.globenewswire.com/news-release/2025/08/11/3130894/11676/en/Veru-Announces-Selection-of-Novel-Modified-Release-Oral-Enobosarm-Formulation-for-Chronic-Weight-Loss-Management-Following-Pharmacokinetic-Clinical-Study.html

GLOBENEWSWIRE
11 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty